Nitric oxide as a unique signaling molecule in the vascular system: A historical overview

Journal of Physiology and Pharmacology

Volumn 53, Issue 4 I, 2002, Pages 503-514

  Ignarro, Louis J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cyclic GMP; Endothelium; Hypertension; Nitroglycerin; NO synthase; Platelet aggregation; Vasodilatation

Indexed keywords

CYCLIC GMP; GLYCERYL TRINITRATE; NEUROTRANSMITTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SPASMOLYTIC AGENT;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; ESSENTIAL HYPERTENSION; IMPOTENCE; MAMMAL CELL; NEUROTRANSMISSION; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; STROKE; THROMBOCYTE AGGREGATION; VASCULAR DISEASE;

ANIMALS; BLOOD VESSELS; HUMANS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITROGLYCERIN; PENILE ERECTION; SIGNAL TRANSDUCTION; VASOMOTOR SYSTEM;

EID: 0036912721     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (69)

1. Gruetter C A, Barry B K, McNamara D B, Gruetter D Y, Kadowitz P J, Ignarro L J. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Protein Phosphor Res 1979; 5:211-224.
2. Furchgott R F, Zawadzki J V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:373-376.
3. Mellion B T, Ignarro L J, Ohistein E H, Pontecorvo E G, Hyman A L, Kadowitz P J. Evidence for the inhibitory role of guanosine 3′,5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 1981; 57:946-955.
4. Mellion B T, Ignarro L J, Myers C B, Ohistein E H, Ballot B A, Hyman A L, Kadowitz P J. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. Mol Pharmacol 1983; 23:653-664.
5. Gruetter C A, Barry B K, McNamara D B, Kadowitz P J, Ignarro L J. Coronary arterial relaxation and guanylate cyclas activation by cigarette smoke, N′-nitrosonornicotine and nitric oxide. J Pharmacol Exp Ther 1980a; 214:9-15.
6. Gruetter D Y, Gruetter C A, Barry B K, Baricos W H, Hyman A L, Kadowitz P J, Ignarro L J. Activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside, and nitrosoguanidine: Inhibition by calcium, lanthanum, and other cations, enhancement by thiols. Biochem Pharmacol 1980b; 29:2943-2950.
7. Gruetter C A, Gruetter D Y, Lyon J E, Kadowitz P J, Ignarro L J. Relationship between cyclic guanosine 3′,5′-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: Effects of methylene blue and methemoglobin. J Pharmacol Exp Ther 1981; 219:181-186.
8. Ignarro L J, Gruetter C A. Requirement ofthiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: Possible involvement of S-nitrosothiols. Biochim Biophys Acta 1980; 631:221-231.
9. Ignarro L J, Edwards J C, Gruetter D Y, Barry B K, Gruetter C A. Possible involvement of S-nitrosothiols in the activation of guanylate cyclase by nitroso compounds. FEBS Lett 1980a; 110:275-278.
10. Ignarro L J, Barry B K, Gruetter D Y, Edwards J C, Ohistein E H, Gruetter C A, Baricos W H. Guanylate cyclase activation of nitroprusside and nitrosoguanidine is related to formation of S-nitrosothiol intermediates. Biochem Biophys Res Commun 1980b; 94:93-100.
11. Ignarro L J, Lippton H, Edwards J C, Baricos W H, Hyman A L, Kadowitz P J, Gruetter C A. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981; 218:739-749.
12. Ohistein E H, Barry B K, Gruetter D Y, Ignarro L J. Methemoglobin blockade of coronary arterial soluble guanylate cyclase activation by nitroso compounds and its reversal with dithiothreitol. FEES Lett 1979; 102:316-320.
13. Katsuki S, Arnold W, Mittal C, Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 1977; 3:23-35.
14. Needleman P, Johnson E M. Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther 1973; 184:709-715.
15. Needleman P, Jakschik B, Johnson E M, Sulfhydryl requirement for relaxation of vascular smooth muscle. J Pharmacol Exp Ther 1973; 187:324-331.
16. Axelsson K L, Anderson R G G, Wikberg J E S. Vascular smooth muscle relaxation by nitro compounds: Reduced relaxation and cGMP elevation in tolerant vessels and reversal of tolerance by dithiothreitol. Acta Pharmacol Toxicol 1982; 50:350-357.
17. Axelsson K L, Andersson R G. Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover. Eur J Pharmacol 1983; 88:71-79.
18. Horowitz J D, Antman E M, Lorell B H, Barry W H, Smith T W, Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. Circulation 1983; 68:1247-1253.
19. Keith R A, Burkman A M, Sokoloski T D, Fertel R. H. Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle. J Pharmacol Exp Ther 1982; 221:525-531.
20. May D C, Popma J J, Black W H, Schaefer S, Lee H R, Levine B D, Hillis L D. In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries. N Engl J Med 1987; 17:805-809.
21. Packer M, Lee W H, Kessler P D, Gottlieb S S, Medina N, Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 1987; 317:799-804.
22. Winniford M D, Kennedy P L, Wells P J, Hillis L D. Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine. Circulation 1986; 73:138-142.
23. DeRubertis F R, Craven P A. Calcium-independent modulation of cyclic GMP and activation of guanylate cyclase by nitrosamines. Science 1976; 193:897-899.
24. Ignarro L J, Kadowitz P J. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol 1985; 25:171-191.
25. Gerzer R, Hofmann F, Schultz G. Purification of a soluble, sodium-nitroprussidestimulated guanylate cyclase from bovine lung. Eur J Biochem 1981; 116:479-486.
26. Gerzer R, Radany E W, Garbers D L. The separation of the heme and apoheme forms of soluble guanylate cyclase. Biochem Biophys Res Commun 1982; 108:678-686.
27. Ignarro L J, Wood K S, Wolin M S. Activation of purified soluble guanylate cyclase by protoporphyrin IX Proc Natl Acad Sci USA 1982a; 79:2870-2873.
28. Ignarro L J, Degnan J N, Baricos W H, Kadowitz P J, Wolin M S. Activation of purified guanylate cyclase by nitric oxide requires heme: Comparison of heme-deficient, hemereconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochim Biophys Acta 1982b; 718:49-59.
29. Ignarro L J, Wood K S, Ballot B, Wolin M S. Guanylate cyclase from bovine lung: Evidence that enzyme activation by phenylhydrazine is mediated by iron-phenyl hemoprotein complexes. J Biol Chem 1984a; 259:5923-5931.
30. Ignarro L J, Ballot B, Wood K S. Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. J Biol Chem 1984b; 259:6201-6207.
31. Ohistein E H, Wood K S, Ignarro L J. Purification and properties of heme-deficient hepatic soluble guanylate cyclase: Effects of heme and other factors on enzyme activation by NO, NO-heme, and protoporphyrin IX Arch Biochem Biophys 1982; 218:187-198.
32. Wolin M S, Wood K S, Ignarro L J. Guanylate cyclase from bovine lung: A kinetic analysis of the regulation of the purified soluble enzyme by protoporphyrin IX, heme, and nitrosyl-heme. J Biol Chem 1982; 257:13312-13320.
33. Ignarro L J, Wood K S, Wolin M S. Regulation of purified soluble guanylate cyclase by porphyrins and metalloporphyrins: A unifying concept. Adv Cyclic Nucleotide Protein Phosphor Res 1984c; 17:267-274.
34. 2+ sources Chem Biol 1996; 3:655-659.
35. Gorren A C, Schrammel A, Schmidt K, Mayer B, Decomposition of S-nitrosoglutathione in the presence of copper ions and glutathione. Arch Biochem Biophys 1996; 330:219-228.
36. Williams D L. S-nitrosothiols and role of metal ions in decomposition to nitric oxide. Methods Enzymol 1996; 268:299-308.
37. Ignarro L J, Buga G M, Wood K S, Byrns R E, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987a; 84:9265-9269.
38. Ignarro L J, Byrns R E, Buga G M, Wood K S. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987b; 61:866-879.
39. Palmer R M, Ferrige A G, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-526.
40. Ignarro L J, Harbison R G, Wood K S, Kadowitz P J. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: Stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther 1986a; 237:893-900.
41. Ignarro L J, Wood K S, Byrns R E. Pharmacological and biochemical properties of endothelium-derived relaxing factor (EDRF): Evidence that EDRF is closely related to nitric oxide (NO) radical (abstract). Circulation 1986b; 74:11-287.
42. Gryglewski R J, Palmer R M J, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320:454-456.
43. Rubanyi G M, Vanhoutte P M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986; 250:H822-H827.
44. Beckman J S, Beckman T W, Chen J, Marshall P A, Freeman B A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87:1620-1624.
45. Azuma H, Ishikawa M, Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 1986; 88:411-415.
46. Ignarro L J. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989; 65:1-21.
47. Ignarro L J, Byrns R E, Wood K S. Endothelium-dependent modulation of cGMP levels and intrinsic smooth muscle tone in isolated bovine intrapulmonary artery and vein. Circ Res 1987c; 60:82-92.
48. Aisaka K, Gross S S, Griffith O W, Levi R. NO-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: Does nitric oxide regulate blood pressure in vivo? Biochem Biophys Res Commun 1989; 160:881-886.
49. Rees D D, Palmer R M, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989; 86:3375-3378.
50. Vargas H M, Cuevas J M, Ignarro L J, Chaudhuri G. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: Evidence for continuous basal EDRF release. J Pharmacol Exp Ther 1991; 257:1208-1215.
51. Bevan J A, Joyce E H. Flow-dependent dilation in myograph-mounted resistance artery segments. Blood Vessels 1988; 25:101-104.
52. Buga G M, Gold M E, Fukuto J M, Ignarro L J. Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 1991; 17:187-193.
53. Hintze T H, Vatner S F. Reactive dilation of large coronary arteries in conscious dogs. Circ Res 1984; 54:50-57.
54. Holtz J, Giesler M, Bassenge E. Two dilatory mechanisms of antianginal drugs on epicardial coronary arteries in vivo: Indirect, flow-dependent, endothelium-mediated dilation and direct smooth muscle relaxation. Z Kardiol 1983; 72:98-106.
55. Holtz J, Forstermann U, Poh, U, Giesler M, Bassenge E. Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: Effects of cyclooxygenase inhibition. J Cardiovasc Pharmacol 1984; 6:1161-1169.
56. Hull S S, Kaiser L, Jaffe M D, Sparks H V. Endothelium-dependent flow-induced dilation of canine femoral and saphenous arteries. Blood Vessels 1986; 23:183-198.
57. Kaiser L, Hull S S, Jr., Sparks H V, Jr. Methylene blue and ETYA block flow-dependent dilation in canine femoral artery. Am J Physiol 1986; 250:H974-H981.
58. Rubanyi G M, Romero J C, Vanhoutte P M. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986; 250:H1145-H1149.
59. Tesfamariam B, Halpern W, Osol G. Effects of perfusion and endothelium on the reactivity of isolated resistance arteries. Blood Vessels 1985; 22:301-305.
60. Ayajiki K, Kindermann M, Hecker M, Fleming I, Busse R. Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells. Circ Res 1996; 78:750-758.
61. Fleming I, Bauersachs J, Busse R. Calcium-dependent and calcium-independent activation of the endothelial NO synthase. J Vasc Res 1997; 34:165-174.
62. Rogers N E, Ignarro L J. Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem Biophys Res Commun 1992; 189:242-249.
63. Buga G M, Griscavage J M, Rogers N E, Ignarro L J. Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 1993; 73:808-812.
64. Cohen G A, Hobbs A J, Fitch R M, Zinner M J, Chaudhuri G, Ignarro L J. Nitric oxide regulates endothelium-dependent vasodilator responses in rabbit hindquarters vascular bed in vivo. Am J Physiol 1996; 271:H133-H139.
65. Abu-Soud H M, Wang J, Rousseau D L, Fukuto J M, Ignarro L J, Stuehr D J. Neuronal nitric oxide synthase self-inactivates by forming a ferrous-nitrosyl complex during aerobic catalysis. J Biol Chem 1995; 270:22997-23006.
66. Ignarro L J, Bush P A, Buga G M, Wood K S, Fukuto J M, Rajfer J. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1990; 170:843-850.
67. Rajfer J, Aronson W J, Bush P A, Dorey F J, Ignarro L J. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992; 326:90-94.
68. Trigo-Rocha F, Aronson W J, Hohenfellner M, Ignarro L J, Rajfer J, Lue T F. Nitric oxide and cGMP: Mediators of pelvic nerve-stimulated erection in dogs. Am J Physiol 1993; 264:H419-H422.
69. Bush P A, Gonzalez N E, Ignarro L J. Biosynthesis of nitric oxide and citrulline from L-arginine by constitutive nitric oxide synthase present in rabbit corpus cavernosum. Biochem Biophys Res Commun 1992; 186:308-314.